1. Home
  2. SNSE vs MRM Comparison

SNSE vs MRM Comparison

Compare SNSE & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • MRM
  • Stock Information
  • Founded
  • SNSE 2005
  • MRM 2000
  • Country
  • SNSE United States
  • MRM Japan
  • Employees
  • SNSE N/A
  • MRM N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • MRM Other Consumer Services
  • Sector
  • SNSE Health Care
  • MRM Consumer Discretionary
  • Exchange
  • SNSE Nasdaq
  • MRM Nasdaq
  • Market Cap
  • SNSE 12.3M
  • MRM 12.2M
  • IPO Year
  • SNSE 2021
  • MRM 2020
  • Fundamental
  • Price
  • SNSE $0.48
  • MRM $1.07
  • Analyst Decision
  • SNSE Strong Buy
  • MRM
  • Analyst Count
  • SNSE 3
  • MRM 0
  • Target Price
  • SNSE $4.33
  • MRM N/A
  • AVG Volume (30 Days)
  • SNSE 272.7K
  • MRM 508.9K
  • Earning Date
  • SNSE 11-14-2024
  • MRM 01-01-0001
  • Dividend Yield
  • SNSE N/A
  • MRM N/A
  • EPS Growth
  • SNSE N/A
  • MRM N/A
  • EPS
  • SNSE N/A
  • MRM N/A
  • Revenue
  • SNSE N/A
  • MRM $44,462,062.00
  • Revenue This Year
  • SNSE N/A
  • MRM N/A
  • Revenue Next Year
  • SNSE N/A
  • MRM N/A
  • P/E Ratio
  • SNSE N/A
  • MRM N/A
  • Revenue Growth
  • SNSE N/A
  • MRM 2.80
  • 52 Week Low
  • SNSE $0.38
  • MRM $0.90
  • 52 Week High
  • SNSE $1.94
  • MRM $8.39
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 45.51
  • MRM 29.36
  • Support Level
  • SNSE $0.42
  • MRM $0.90
  • Resistance Level
  • SNSE $0.50
  • MRM $1.25
  • Average True Range (ATR)
  • SNSE 0.04
  • MRM 0.23
  • MACD
  • SNSE 0.00
  • MRM -0.06
  • Stochastic Oscillator
  • SNSE 44.44
  • MRM 6.79

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.

About MRM MEDIROM Healthcare Technologies Inc.

MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.

Share on Social Networks: